ClinicalTrials.gg
RecruitingNCT07786467Updated Sep 23, 2026

Optimizing Lymphatic Pumping for Influenza Vaccine Responses in Vulnerable Populations

An interventional study of Osteopathic Manipulation and Osteopathic manipulation in No Disease or Condition is Being Directly Studied and The Focus of the Study in Healthy Volunteers, sponsored by Lake Erie College of Osteopathic Medicine. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-23.

Sponsored by Lake Erie College of Osteopathic Medicine · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The investigators are studying if a specific osteopathic manipulative treatment protocol can improve the immune response (antibody titers) to seasonal influenza vaccination in vulnerable populations, including patients with advanced age and/or adiposity.

02

Conditions studied

  • No Disease or Condition is Being Directly Studied
  • The Focus of the Study in Healthy Volunteers

Browse trials for

Keywords

  • Osteopathic Manipulation
  • Influenza vaccine
  • Aging
  • Body composition
03

In context

Influenza, Human

2,356 studies on the registry are indexed under Influenza, Human; 184 are open to participants now.

This study's planned enrollment of 50 is below the median of 227 across 1,957 interventional studies indexed under Influenza, Human.

Browse Influenza, Human studies →

Lead sponsor

Lake Erie College of Osteopathic Medicine is the lead sponsor of 8 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Willing to receive OMT
  • Willing to receive influenza vaccine
  • Older than 18 years of age

Exclusion criteria

Exclusion Criteria:

  • Younger than 18 years of age
  • Pregnancy or lactation
  • Unwilling to receive the influenza vaccine
  • Unwilling to receive OMT
  • Open wounds
  • Bone fractures
  • Moderate to severe osteoporosis
  • Severe
  • Current/active infections
  • Mononucleosis infection within past 6 months
  • Liver cirrhosis
  • Cancer or disease
  • History of DVT, PE, or blood clotting disorder
  • Individuals taking blood thinning medications, except aspirin
  • Having a pacemaker or other thoracic medical devices
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

Metastases

Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Active comparator
    Thoracic pump only

    Only thoracic inlet myofascial release

    Other: Osteopathic Manipulation

  • Sham comparator
    No intervention

    No intervention pre- or post-influenza vaccination.

    Other: Sham

  • Experimental
    Complete lymphatic pumping

    Multiple sites of OMT to occur post-influenza vaccination.

    Other: Osteopathic manipulation

Interventions

  • OtherOsteopathic Manipulation

    In this intervention, participants will receive 5 minutes of thoracic inlet myofascial release 2 days prior to influenza vaccination, the day of influenza vaccination and 4 days post-influenza vaccination.

  • OtherOsteopathic manipulation

    In this intervention, participants will receive osteopathic manipulation 2 days prior to influenza vaccination, the day of influenza vaccination, and 4 days post-influenza vaccination. The OMT will include thoracic inlet myofascial release, pectoral traction, rib raising, doming of the diaphragm, pelvic diaphragm release, popliteal fossa release, plantar myofascial release, passive Miller thoracic pump, liver pump, and spleen pump.

  • OtherSham

    In this intervention, participants will receive no osteopathic treatments

06

What researchers measure

Primary outcomes

  1. Hemagglutinin inhibition assay

    Hemagglutinin inhibition assay assess the antibody titers in patient's blood.

    Time frame: baseline and 4 weeks post vaccination

07

Study locations

1 of 1 sites recruiting
  • Plaza 38 Medical Offices
    Erie, Pennsylvania 16509, United States
    Recruiting
    • Jacob Cukierski, DO · Contactjcukierski@lecom.edu · 814-860-8414
    • Stephany Esper, DO · Contactsesper@lecom.edu · 814-860-8463
    • David Duriancik, Ph.D. · Principal investigator
    • Jonathan Sharp, BS · Sub investigator
    • Jan Hendryx, DO · Sub investigator
    • Stephany Esper, DO · Sub investigator
    • Jacob Cukierski, DO · Sub investigator
    • Amanda Parker, BS · Sub investigator
    • Kayleigh Skolnick, BS · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07786467
Lead sponsor
Lake Erie College of Osteopathic Medicine
Responsible party
David Duriancik (Associate Professor, Lake Erie College of Osteopathic Medicine) — Principal investigator
First posted
Aug 26, 2026
Start date
Sep 2026 (estimated)
Primary completion
Oct 2027 (estimated)
Completion
Oct 2027 (estimated)
Last update
Sep 23, 2026

Study contacts

David Duriancik, Ph.D.
Contact
dduriancik@lecom.edu
814-860-5139
Irv Freeman, J.D., Ph.D.
Contact
ifreeman1@lecom.edu
724-552-2870
David Duriancik, Ph.D.
principal investigator · Lake Erie College of Osteopathic Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion